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Here we describe the cloning and characterization of the Schistosoma mansoni Alkaline Phosphatase
(SmAP), previously identiﬁed in the tegument of adult worms. SmAP encodes a complete sequence com-
posed of 536 amino acids containing an N-terminal signal peptide, ﬁve N-glycosylation sites, and a GPI
anchor signal, similar to that described for mammalian orthologs. Real-time RT-PCR and Western blot
experiments suggest a rapid translation as soon as cercariae are transformed into schistosomula. Immu-
nolocalization analysis shows that the protein is widely distributed in the worm tissues, with increased
concentration in the vitelline glands of female parasites. Furthermore, the surface localization of this
enzyme was quantitatively supported by its enzymatic activity in live ex vivo or cultured parasites
throughout the life cycle stages. The fact that cercariae accumulate large amounts of SmAP mRNA, which
rapidly translates into protein upon schistosomula transformation, indicates it may have an important
role in host invasion.
 2011 Elsevier Inc. Open access under the Elsevier OA license. 1. Introduction
Schistosomiasis is considered a neglected tropical disease by
WHO and the search for a vaccine is one of the main goals of
Tropical Disease Research (Morel, 2000). The currently used anti-
schistosomal drugs (e.g. praziquantel and/or oxamniquine) do
not prevent reinfection (Bergquist et al., 2002) and potentially in-
crease the likeliness for the parasite to acquire resistance (Al-
Sherbiny et al., 2003). The Schistosoma mansoni and Schistosoma
japonicum transcriptomes (Hu et al., 2003; Verjovski-Almeida
et al., 2003) and genomic sequencing projects (Berriman et al.,
2009; Zhou et al., 2009) opened new opportunities for diagnosis,
drug discovery, and vaccine research.
The Alkaline Phosphatase from S. mansoni (SmAP) is so far one
of the most studied molecules on the parasite–host interface
(Ballen et al., 2002; Bhardwaj and Skelly, 2011; Cesari, 1974; Dus-
anic, 1959; Nimmo-Smith and Standen, 1963; Payares et al., 1984),
although it has not been well characterized at the molecular level.
It is a glycosylated enzyme (Payares et al., 1984) associated with
the cell membrane (Cesari, 1974). It seems to have a fundamental
role in the parasite’s physiology, removing phosphate groups from
organic molecules (Cesari et al., 1981). This protein may be impor-ite).
evier OA license. tant in the context of immune evasion within the host, by metab-
olizing the intrinsic host’s molecular signals of danger released
during skin and blood vein invasion (Bhardwaj and Skelly, 2009,
2011). The Alkaline Phosphatase activity was initially detected in
different tissues of the adult parasite’s body (Cesari, 1974). It was
used as a marker for tegument surface plasma membrane enrich-
ment (Braschi et al., 2006; Roberts et al., 1983). Additionally, it
has been characterized as a surface-exposed tegument protein by
proteomic studies (Braschi et al., 2006; Braschi and Wilson,
2006). This protein becomes even more exposed on the parasite’s
surface after treatment with praziquantel and the co-administra-
tion of an antisera that inhibits Alkaline Phosphatase activity
increases the killing of female worms in vivo (Fallon et al., 1994).
A more recent study showed that SmAP, among others, is recog-
nized by antisera from infected Rhesus macaques which succeeded
in eliminating adult worms. The concentration of antibodies was
considered as a remarkable feature for worm elimination in high-
responder individuals (Wilson et al., 2008). It was assumed that
these protein targets should be continuously recognized and func-
tionally inhibited by neutralizing antibodies. A study has been
recently published in which the role of SmAP in degrading AMP
was demonstrated (Bhardwaj and Skelly, 2011). With these and
other pieces of evidence, SmAP has been proposed as a vaccine
candidate (Braschi and Wilson, 2006; Verjovski-Almeida et al.,
2003). In this context, we have characterized the molecular traits,
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during the parasite’s life cycle. We have also investigated the sur-
face enzymatic activity in different parasite stages and its putative
inhibition by antisera.2. Materials and methods
2.1. Biological material
The S. mansoni adult worms (BH strain) were obtained from per-
fusion of infected hamsters. Eggs, miracidia, cercariae, and schisto-
somula were obtained as previously described (Verjovski-Almeida
et al., 2003). Experimental animal protocols were approved by the
Animal Use Ethics Committee of Instituto Butantan (CEUAIB Proto-
col N 597/09, São Paulo, Brazil).
2.2. Cloning and sequence analysis
Total RNA was isolated from adult worms using TRIzol reagent
(Life Technologies), followed by mRNA puriﬁcation with oligo(dT)-
cellulose columns according to the manufacturer’s instructions (GE
Healthcare). Speciﬁc oligonucleotide was designed based on SmAE
607243 contig sequence (Verjovski-Almeida et al., 2003) to per-
form rapid ampliﬁcation of 30 cDNA End (RACE) (Life Technologies)
according to manufacturer’s instructions. After the determination
of the 30 end, the SuperScriptTM First-Strand Synthesis System
for RT-PCR (Life Technologies) was used for SmAP full-length cDNA
generation following the manufacturer’s protocol. The 50 ATG CTT
CCA ACT GTC TTA TCG AC 30 forward and 50 GAT TAC ATA CTT
TCA CAT GTT TTA TTA TG 30 reverse primers were used to amplify
the complete open reading frame of SmAP. The obtained PCR frag-
ment was cloned into pGEM-T easy vector (Promega) and se-
quenced to conﬁrm its identity. Sequence alignments were done
using the ClustalW software (Higgins, 1994); determination of
the molecular weight and pI were done with the Compute pI/Mw
Tool algorithm available at the Swiss Institute of Bioinformatics
(http://www.expasy.org/cgi-bin/pi_tool); detection of the signal
peptide and transmembrane region were performed with the Sig-
nalP algorithm, (Bendtsen et al., 2004) and TMHMM version 2.0
(Sonnhammer et al., 1998) respectively, and N- and O-glycosyla-
tion sites with the NetNGlyc version 1.0 and YingOYang algorithms
(Gupta and Brunak, 2002). Homology modeling was done using
Swiss-PDB Viewer 4.0.1 software (Guex and Peitsch, 1997) and
putative conformational B-cell epitope prediction was done with
the Discotope 1.2 algorithm (Haste Andersen et al., 2006).
2.3. Real-time RT-PCR
Total RNA from eggs, miracidia, cercariae, 7-day old cultured
schistosomula, adult worms, male and female were extracted using
TRIzol (Life Technologies) according to manufacturer’s protocol.
RNA quantitation was carried out with ND-1000 spectrophotome-
ter (NanoDrop Technologies) and its quality veriﬁed with an
Agilent 2100 Bioanalyzer. For the cDNA synthesis, RNA samples
from at least three different extractions, were ﬁrst treated with
RNase-free DNase RQ1 (Promega), and then the Superscript III
reverse transcriptase was added for the cDNA synthesis, using
randomic primers, following instructions from the manufacturer
(Life Technologies).
For quantitative PCR (qPCR), primers were designed using the
Primer Express algorithm annealing right above splicing sites to
avoid genomic DNA ampliﬁcation. The primers designed this way
were: forward, 50 CGC CTC TAA AGC AGG ATT TTC TAC 30, and re-
verse, 50 GTC AAA AGT TCC ATC AAA CCA GC 30, which together
with the synthesized cDNA and SYBR Green (Applied Biosystems)were used for ampliﬁcation following 10 min at 95 C, 40 cycles
of 10 s at 95 C, followed by 1 min at 60 C and monitored for ﬂuo-
rescence emission from SYBR Green only when intercalated in
dsDNA in a 7300 Real Time PCR System (Applied Biosystems).
Each cycle’s ﬂuorescence was collected, analyzed and results
shown as ﬂuorescence (DRn) vs. cycles. The ampliﬁcation curves
were used to determine the number of cycles that reached the
threshold (Ct). With these values we could compare the results ob-
tained with SmAP expression and the control housekeeping gene,
a-tubulin (Accession: M80214) for all the stages analyzed, using
the following formula: fold change = 2DDCt (Livak and Schmittgen,
2001; Pfafﬂ, 2001). Graphics are shown as relative fold change vs.
life cycle stages, in order to show how many times a gene is more
expressed in a stage compared to any other stage. These differ-
ences were statistically analyzed by ANOVA and later, by Tukey’s
with help of the statistical analysis software GraphPad Prism 4.
2.4. Expression and puriﬁcation of recombinant Alkaline Phosphatase
The coding sequence of the S. mansoni Alkaline Phosphatase
(SmAP) was ﬁrst ampliﬁed from a cDNA obtained from total mRNA
from S. mansoni adult worms by PCR with the primers P1: 50 CAC
CTC GAG AAA TCG TCC TTA TTG AAT 30, and P2: 50 CAT GGT ACC
TCT ATC GAG ATC CAT TGT TTC C 30. The ampliﬁed fragments were
inserted directionally into the pAE expression vector (Ramos et al.,
2004) and conﬁrmed by automatic sequencing (ABI 377, PE Ap-
plied Biosystems). Escherichia coli BL21 Star (DE3) pLysS strain
transformed with pAE-smAP was grown overnight as a pre-inocu-
lum in 10 mL of 2YT medium. This culture was then transferred to
a 1 L ﬂask containing 600 mL of 2YT medium, and allowed to grow
until log phase and then induced with 1 mM IPTG. After induction,
cells were collected by centrifugation and resuspended in lysis buf-
fer (50 mM Tris–HCl, pH 8.5 plus Protease Inhibitor Cocktail 1
(Sigma)), and sonicated in an ice bath (40 Hz, 1s pulse, 10 min).
After centrifugation at 20,000g, inclusion bodies were separated
and resuspended in washing buffer (50 mM Tris–HCl pH 8.8,
10 mM EDTA, 2% Triton X-100) and centrifuged again at 20,000g,
and after two more washing steps, the resulting inclusion bodies
were ﬁnally solubilized with 8 M urea. These were then refolded
overnight by pulsed dilution (100) in a refolding buffer (Tris
50 mM pH 8.5 and b-mercaptoethanol 5 mM), ﬁltered through
0.8 lm-pore ﬁlters (Millipore), and ﬁnally nickel-afﬁnity puriﬁed
using a 5 mL HisTrap™ HP column (GE Healthcare). Protein con-
centrations were determined by Lowry’s method (Bio-Rad DC Pro-
tein Assay) using bovine serum albumin as a standard. In order to
monitor the purity of the recombinant protein along the whole
puriﬁcation process, equal amount of samples (20 lg) were elec-
trophoresed in 12% SDS–PAGE and stained afterwards with Coo-
massie Brilliant Blue R-250 (Sigma). The protein purity was
determined by densitometric analysis using ImageJ software
(http://rsweb.nih.gov/ij/).
2.5. Polyclonal antibody production
Rats were immunized with 100 lg of the puriﬁed recombinant
protein with Freund’s adjuvant according to the following sche-
dule: a ﬁrst immunization, and three subsequent boosts at every
14 days, and a ﬁnal bleeding 2 weeks after the third boost. These
sera obtained were immunoadsorbed with an extract of E. coli
transformed with empty pAE vector and utilized in the Western
blot and immunolocalization assays.
2.6. Protein expression proﬁle along life cycle stages
Total protein extracts from eggs, miracidia, cercariae, schisto-
somula, and adult worms were prepared in 40 mM Tris, pH 7.4,
286 B.O. Araujo-Montoya et al. / Experimental Parasitology 129 (2011) 284–2912% SDS plus protease inhibitor through sonication, as described
above. The samples were centrifuged at 20,000g for 30 min at
4 C and the supernatant was recovered and used for the assays.
The tegument extract from adult worms was obtained by a
freeze/thaw/vortex procedure, as previously described (Roberts
et al., 1983). Brieﬂy, frozen worms (1000) were thawed on ice in
the presence of 1 mL ice-cold RPMI medium plus protease inhibi-
tors (Protease inhibitor cocktail; Sigma); 10 vortex pulses at max-
imum speed during 1 s each, to detach the tegument. After the
stripped worms had settled, the supernatant containing pieces of
tegument was collected and sonicated. Protein concentrations
were determined with a DC Protein Assay (Bio-Rad) using BSA as
a standard. For Western blot, puriﬁed recombinant SmAP (rSmAP,
25 ng, 80% purity) and total parasite protein extracts (5 lg each)
were subjected to SDS–PAGE (12%) 1D gels under reducing condi-
tions. After transfer onto PVDF membranes (GE Healthcare) and
blocking (Tris 10 mM pH 8.0, 0.3% Tween 20, and 5% [wt/vol]
skimmed milk powder), blots were incubated with immunoad-
sorbed rat antisera against rSmAP in a 1:5000 dilution. After three
washes with Tris 10 mM pH 8.0, blots were incubated with HRP-
conjugated goat anti-rat IgG antibody in a 1:6000 dilution (Pierce
Biotechnology), then washed three times as before and speciﬁc
antibody binding was visualized using the ECL Western Blotting
Detection System (GE Healthcare).
2.7. Deglycosylation experiment
Deglycosylation of native SmAP was carried out as previously
described (Plummer and Tarentino, 1991). Brieﬂy, 20 lg of tegu-
ment or egg extract was denatured for 10 min at 100 C with 1
glycoprotein denaturing buffer (10: 5% SDS, 0.4 M DTT) and then
incubated for 16 h at 37 C with PNGaseF (New England Biolabs)
followed or not by treatment with a set of enzymes for determin-
ing potential O-glycosylations (EDEGLY Kit, Sigma). Negative con-
trols contained the same reagents as samples minus enzyme.
2.8. Immunolocalization of SmAP in adult worms
Freshly perfused adult worms were embedded in OCT medium
(Sakura) in a pre-cooled beaker of isopentane, frozen in liquid N2.
Eight micrometer cryostat sections of adult worms were adhered
to silanized glass slides (DakoCytomation), ﬁxed in acetone for
30 min at 20 C and rehydrated with PBS overnight at 4 C. Slices
were then blocked 4 h with PBS, 0.1% Tween 20 and 10% normal
rabbit serum. Following this, incubations were made with the rat
anti-rSmAP serum (1:200 dilution in the same blocking buffer)
and rhodamine–falloidin (1:100) for 3 h at room temperature.
After washing six times with PBS, 0.1% Tween 20, the slides were
incubated with Alexa Fluor 488 rabbit anti-rat IgG (H + L) (Life
Techonologies) (1:200 dilution). E. coli-immunoadsorbed serum
from naïve rats was used as negative control. Images were ac-
quired in a Zeiss LSM 510 Meta Confocal System, attached to a
Zeiss Axiovert 100 microscope using a 1.2 NA 40 PlanApochro-
matic objective with differential interference contrast and a Band
Pass ﬁlter (BP 500-550 IR) to avoid autoﬂuorescence.
2.9. Activity assay of Alkaline Phosphatase on live stages of the
parasite
We used the synthetic substrate p-Nitrophenyl Phosphate
(pNPP) in a adapted protocol (Cesari et al., 1981) to assess the sur-
face activity of live parasites. We followed two criteria: the ﬁrst
one compared enzymatic activity per surface area of the life cycle
stages and the second one compared activity per parasite number
between male and female adult worms. For the ﬁrst analysis, we
made an estimate of the surface areas of the different stages of in-tact parasites, to roughly normalize them. We considered the sur-
face area of cercaria to be 10,682–20,000 lm2 (Crabtree and
Wilson, 1980; Samuelson and Caulﬁeld, 1985), that from eggs to
be around 16,304 lm2 using an approach to measure the surface
area of a hen egg (Narushin, 2005), and male adult worms to be
around 12,000,000 lm2 without considering the tegument pits
(Smith et al., 1969). Based on these calculations, we used a total
number of 2000 cercariae, 4000 eggs, 1500 7-day old cultured
schistosomula and three male adult worms. In the second analysis,
we used three individuals of each, male and female live ex vivo
adult parasites. All of the specimens were incubated in 100 lL of
the pNPP substrate (Sigma), pH 9.5, for 30 min, after which para-
sites were visually inspected for viability, and ﬁnally the absor-
bance at 405 nm was read on a multiplate ELISA reader
(Multiskan EX, LabSystems). As a control, 100 lL of pNPP were
incubated with 100 lL of PBS; each sample was assessed in tripli-
cate and statistical analysis was performed using ANOVA. For the
antibody blocking assay, adult parasites were incubated in 50 lL
of anti-rSmAP sera for 1 h at 37 C, and then assayed for surface
activity using the same parameters and calculations as mentioned
above.3. Results
3.1. Sequence analysis of Alkaline Phosphatase from S. mansoni
To clone the full-length sequence of the SmAP cDNA, we per-
formed a 30 RACE experiment based on SmAE 607243 contig (Ver-
jovski-Almeida et al., 2003) to determine the 30 end of the gene.
With this information we designed speciﬁc oligonucleotides to am-
plify the full-length SmAP by RT-PCR from adult worm total mRNA.
The resulting full-length cDNA (GenBank Accession HM045783)
proved to be 99% identical to a previously reported SmAP cDNA
[GenBank Accession EU040139, (Ndegwa et al., 2007)], with some
divergences, possibly due to the differences between the two par-
asite strains compared (BH in this study and Puerto Rican in the
former) or to sequencing errors (Supplementary Fig. 1).
Searching the genomic sequence of the corresponding cDNA at
the S. mansoni genome database (www.schistodb.org/Homepage/
Smansoni), we identiﬁed two predicted Alkaline Phosphatase pro-
teins (Smp_155890 and Smp_145290). The sequence identiﬁed in
Smp_155890 turned out to be the same sequence as SmAP,
although with a shorter and divergent 30 end, probably because
its last exon was not correctly predicted (Supplementary Fig. 1).
Subsequent re-alignment analysis of these two sequences on the
corresponding scaffold (supercontig Smp_scaff000188) revealed a
potential misassembly as being responsible for this artifact (data
not shown). On the other hand, Smp_145290 (supercontig
Smp_scaff000103; 881397–886893) shares 88% identity with
SmAP, revealing the presence of polymorphisms all over the se-
quence and differing greatly in the 5th exon; however, this pre-
dicted protein could not be validated with any EST from S.
mansoni databases (data not shown).
The full-length cloned cDNA displayed an ORF of 1698 bp,
encoding a protein of 536 amino acids with a predicted molecular
mass of approximately 59.3 kDa and an isoeletric point of 5.92. The
SmAP protein sequence showed an overall aminoacid sequence
identity of 33–37% to those of Homo sapiens placental Alkaline
Phosphatase, Rattus norvegicus tissue non-speciﬁc Alkaline Phos-
phatase,Mus musculus liver Alkaline Phosphatase, and Canis famili-
aris Alkaline Phosphatase (Fig. 1). SmAP contains the AP signature
sequence (residues 64-495) (outlined by a continuous box in
Fig. 1), and is recognized as part of the Pfam Alkaline Phosphatase
family (PF00245) with an E-value of 8.60  10109. SmAP also con-
tains a putative N-terminal signal peptide (bold characters in
Fig. 1. Sequence alignment of Alkaline Phosphatase (AP) from S. mansoni compared to different mammalian APs [Homo sapiens placental AP (Accession Number M14169),
Rattus norvegicus tissue non-speciﬁc AP (Accession Number BC088399), Mus musculus liver/bone/kidney AP (Accession Number X13409) and Canis familiaris liver/bone/
kidney AP (Accession Number XM_535374)]. Boxed aminoacids correspond to the AP domain. Cysteins are shaded in black, putative GPI-anchor signal is shaded in grey,
putative signal peptides are in bold type, putative transmembrane region is in italics. Active site is marked with (N), residues predicted to bind to magnesium (j), to calcium
(h), to zinc1 (d), to zinc2 (s) and to both magnesium and zinc2 (.).
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characters), characterizing it as a type-I, single-spanning trans-
membrane protein, with its catalytic domain facing the extracellu-lar space. Examining the distribution of potential post-
translational modiﬁcations, a putative signal for GPI anchor modi-
ﬁcation centered on S511 could be identiﬁed. There were also ﬁve
Fig. 3. (A) Transcriptional proﬁle along parasite life cycle stages and (B) between
male and female adult worms. Samples were analyzed by real-time RT-PCR and
data were normalized against the housekeeping a-tubulin gene. The data were
calculated according to the comparative DDCt method and are shown as the fold-
change in SmAP expression relative to (A) 7-day old cultured schistosomula or (B)
male adult parasites. EGG, eggs; MIR, miracidia; CER, cercariae; 7DS, 7-day cultured
schistosomula; ADW, Adult worms; MAL, Males; FEM, Females. ⁄, ⁄⁄, ⁄⁄⁄Represent
statistically signiﬁcant differences, p 6 0.05.
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and Asn445) and a few potential O-glycosylation sites with low-
probability. Comparing the SmAP amino acid sequence with those
of mammalian AP’s (Kozlenkov et al., 2002), we further identiﬁed
three metal atom binding sites: one for magnesium (at positions
Asp73, His185, Thr187, and Glu 338) and two for zinc (Asp 343,
His 347, His 459 for Zinc1; Asp 73, Asp 374, His375, His 377 for
Zinc2). In the mammalian sequence there is a calcium binding site
which is not totally conserved in the SmAP (Phe 298, Ala 299, and
Asp 311). The catalytic center would be a serine residue at position
123 (Kozlenkov et al., 2002) (Fig. 1).
3.2. Homology modeling of the protein and putative B-cell epitope
determination
We searched the closest homolog structure already resolved for
the 3D modeling of the protein. The crystal structure of human pla-
cental Alkaline Phosphatase (PDB entry: 1zed) has an identity to our
sequence of 37%, with an E-value of 4e88. With this template, we
generated a non-glycosylated 3D model of our protein using the
Swiss PDB-Viewer software (Fig. 2). Residues belonging to the active
site and putative conformational B-cell epitopes are highlighted
with a unique color. The aminoacid residues involved inmetal bind-
ing, aswell as the active site, are localized very close to each other in
this model, and we can also see the number of putative B-cell epi-
topes predicted, a couple of them in proximity to the active site
and another one elsewhere on the molecule’s surface.
3.3. Transcriptional pattern along the life cycle stages
Transcriptional levels of SmAP were evaluated in all develop-
mental stages of the life cycle by real-time RT-PCR. Our data re-
vealed that SmAP mRNA is expressed in all stages, with the
highest transcriptional activity observed in the cercariae stage
(50-fold relative to schistosomulum stage), followed by eggs
(20-fold) and adults (6-fold) (Fig. 3A), all of which had statisti-
cally signiﬁcant differences between themselves and also when
compared with miracidia and schistosomula stages. Miracidia
and 7-day old cultured schistosomula levels were the lowest when
compared to other developmental stages. We further determined
that there was no statistically signiﬁcant difference between the
transcriptional patterns of male and female parasites (Fig. 3B).
3.4. Expression of SmAP in different parasite stages
Recombinant SmAP produced in E. coli BL21 Star (DE3) pLysS
was nickel-afﬁnity puriﬁed (80% purity, Supplementary Fig. 2B)Fig. 2. Homology modeling of SmAP. A and B represent two opposite images of the
protein. Active site is a serine residue colored in dark blue and putative
conformational B-cell epitopes are in yellow. Aminoacidic residues predicted to
bind to zinc 1 are in green, to zinc 2 in violet, to magnesium in red, to both
magnesium and zinc 2 in light blue. In orange would be the corresponding calcium
binding residues according to alignment analysis with mammalian sequences.and then used to generate polyclonal antibodies in rats, in order
to analyze the protein expression in the parasite’s life cycle by
Western blot. The SmAP is expressed throughout all analyzed
stages of S. mansoni (Fig. 4A and B) with some particular features.
The lowest expression level was found in cercariae and it can be
observed that protein level continues increasing up to 12 h after
transformation. At the 7-day old schistosomula stage it has de-
creased to levels comparable to that of the cercariae stage. Gender
analysis of adult worms revealed higher expression in females than
in males (Fig. 4A). A weaker band present in females, also observed
in miracidia, is probably a product of degradation during sample
processing. We compared the tegument and stripped worms frac-
tions (Fig. 4C), showing that the protein expression level wasFig. 4. (A) Western blot analysis of the expression of SmAP along different stages of
the parasite’s life cycle. EGG, eggs; MIR, miracidia; CER, cercariae; 3HS, 3-h cultured
schistosomula; 12HS, 12-h cultured schistosomula; 7DS, 7-day cultured schisto-
somula; MAL, Males; FEM, Females. (B) Corresponding Coomassie-stained gel as a
loading control for the amount of protein. (C) SmAP in 20 lg of tegument (TEG) and
stripped worms (SW). (D) Tegument extract under non-reducing conditions. (E)
Deglycosylation of native tegument SmAP; PNGase F, tegumental extract deglyco-
sylated with PNGase F (+) or not (). (F) Deglycosylation of eggs extract; PNGase F,
eggs extract deglycosylated with PNGase F (+) or not ().
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ence of an additional band with a slightly higher molecular mass
in eggs (Fig. 4A). This last feature could reﬂect a product of differ-
ent stage-speciﬁc glycosylation [as previously reported for egg se-
creted glycoproteins (Jang-Lee et al., 2007)], since a potential
second isoform was not found in ampliﬁcations done with SmAP
primers using mRNA from this stage, nor in 50 and 30 RACE exper-
iments (data not shown).3.5. Characterization of SmAP as a N-glycosylated protein
The native SmAP observed in schistosome extracts migrates
with a molecular mass of 65 kDa, higher than the predicted
56 kDa for the mature protein (Fig. 4A). We also observed that
SmAP dimerizes in non-reducing conditions as demonstrated by
the 130 kDa product from tegument extracts (Fig. 4D). In order
to determine if the 65 kDa protein band observed was due to gly-
cosylation, we digested total tegument extracts with a recombi-
nant N-glycosidase F. The Western blot revealed that, after
digestion, the SmAP band shifted migration to a lower molecular
mass, demonstrating that SmAP present in the tegument is N-gly-
cosylated (Fig. 4E). Furthermore, deglycosylation of the egg extract
revealed two bands, the lower with the expected size for the stud-
ied protein and the second one still having a higher molecular mass
(Fig. 4F), which could not be further deglycosylated when treated
with enzymes speciﬁc for O-deglycosylation (data not shown).3.6. Immunolocalization of SmAP in parasite tissues
We performed immunolocalization experiments with the pur-
pose of determining the protein distribution in adult worm tissues.
In male, SmAP is localized in almost all tissues of the parasite
(Fig. 5A). It is also possible to see ﬂuorescence in the tegument,
cytoplasmic projections and cytons laying beneath the muscle
layer (Fig. 5C). In females, there is a remarkable ﬂuorescence in
the region of the vitelline glands (Fig. 5D) and a lower uniform
ﬂuorescence in the parenchyma. Parasites treated with rat naïveFig. 5. Immunolocalization of SmAP in transversal section of adult worms. (A)
Fluorescence confocal microscopy image of male and female sections, SmAP (green,
Alexa Fluor 488). (B) Differential contrast image of (A). (C) Inset of male section,
tegument (TEG), cytoplasmic projection (CP), cyton (CYT), and parenchyma (PAR);
the muscle layer (ML) is labeled in red (phalloidin-rhodamin). (D) Inset of female
section, vitelline gland (VG).serum showed no ﬂuorescence under confocal microscopy obser-
vation (data not shown).
3.7. Alkaline Phosphatase activity in the different stages of live
parasites
We determined the Alkaline Phosphatase activity on the surface
of live parasites across the different life stages normalized by sur-
face area. The lowest activity was observed in the 7 day-old cul-
tured schistosomula. There was a statistically signiﬁcant
difference among all stages, except when comparing eggs with
cercariae (Fig. 6A). In comparing genders, in this case normalized
by number of parasites, females showed the highest activity levels,
twice the activity of male worms. This is very signiﬁcant, especially
considering that females have a smaller surface area (Fig. 6B).
Antibodies raised in rats against the recombinant protein were
used to investigate possible inhibition of the activity of the native
enzyme. Live adult parasites were incubated with anti-rSmAP anti-
sera and enzymatic activity of Alkaline Phosphatase evaluated. No
inhibition in AP activity was detected as compared to parasites
incubated with naïve sera (data not shown).
4. Discussion
In this report, we described the molecular cloning of the full-
length cDNA Alkaline Phosphatase from S. mansoni. Based on
sequence comparisons with the previously reported SmAP (Ndeg-
wa et al., 2007) and the S. mansoni genome prediction
(Smp_155890), we conclude that our cDNA better represents the
SmAP sequence. We also believe that Smp_145290 may be a
non-transcribed gene, since it was not found in either 30 or 50 RACE
experiments, raising questions about the existence of this putative
protein of the same Alkaline Phosphatase family.
The SmAP protein sequence shows a putative transmembrane
region and a GPI anchor signal prediction. This could indicate that
the protein may be associated with the plasma membrane by these
two mechanisms, as has been described for the tetraspanin, Sm23Fig. 6. Alkaline Phosphatase activity assay on live parasites. (A) Comparison
between stages, normalized for surface area of each stage. (B) Comparison between
genders, normalized for the number of individuals (three of each). The substrate
used was a ready-to-use solution of p-Nitrophenyl Phosphate incubated with each
stage for 30 min at 37 C, and the absorbance read on a multiplate ELISA reader.
Bars represent means ± S.D. of one experiment representative of three independent
experiments. EGG, eggs; CER, cercariae; 7DS, 7-day cultured schistosomula; MAL,
Males; FEM, Females. ⁄, ⁄⁄, ⁄⁄⁄Represent statistically signiﬁcant differences, p value
< 0.05.
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site’s membrane has been previously observed (Cesari, 1974) and
the treatment of live worms with Phosphatidylinositol-Phospholi-
pase C removes SmAP from the tegument surface (Castro-Borges
et al., 2011). The 65 kDa predicted size of the glycosylated mono-
mer (Ballen et al., 2002; Cesari et al., 1981; Pujol and Cesari, 1990)
was conﬁrmed by our results, as well as the 130 kDa dimer. Our
experiments with PNGaseF also support that SmAP is N-glycosyl-
ated, agreeing with previous observations (Payares et al., 1984).
The identiﬁcation of an extra SmAP protein band in eggs by Wes-
tern blot should be further investigated, since it could constitute
a product of post-translational modiﬁcation. This higher band in
eggs is strongly recognized by the anti-SmAP sera and is also N-
glycosylated. The anti-SmAP serum was raised using a recombi-
nant protein produced in E. coli, so a cross-reaction with a different
protein due to oligosaccharide moieties can be excluded. Addition-
ally, the analysis of the genome revealed the presence of an iso-
form (Smp_145290), which could not be ampliﬁed by either 30 or
50 RACE experiments using RNA from eggs, nor validated in any
transcriptome study; hence, it is not likely that this isoform is pres-
ent in this stage. Our hypothesis is that SmAP is O-glycosylated.
However, O-deglycosylation with enzymes speciﬁc for mammalian
glycoproteins failed. It is possible that the mammalian-speciﬁc en-
zymes do not recognize the schistosome O-glycosylation properly.
It is interesting to note that there is a very high transcriptional
activity in the cercarial stage, which is not immediately translated
into protein, since protein levels are very low in this stage. How-
ever, they rapidly increase following host penetration until at least
12 h. At 7 days, however, protein levels have decreased to levels
comparable to those of cercariae, as well as the transcriptional
activity. A different transcriptional proﬁle has been recently re-
ported for this same SmAP along the life stages of the parasite
(Bhardwaj and Skelly, 2011). In this respect, it is noteworthy that
we have performed qRT-PCR with three different cDNA libraries
from each of these stages and observed that all three gave identical
patterns of transcriptional levels among life cycle stages, with spe-
cial note to cercariae and 7-day old schistosomula, where marked
differences were observed here as compared to (Bhardwaj and
Skelly, 2011). These differences can be ascribed to the use of differ-
ent gene normalizer controls and/or due to the use of different
cDNA libraries. Our results support the hypothesis that, after cerc-
arial transformation, schistosomula may require SmAP messenger
RNA that had been transcribed in the cercarial stage to be rapidly
translated into protein as a means to adapt to a new hostile in-
tra-host environment. Interestingly, a similar pattern of expression
has been observed for SmTNF-alpha receptor, which is most highly
expressed in cercariae and is believed to represent a way for the
parasite to be able to respond to human TNF-alpha ligand when re-
cently transformed schistosomula penetrate the human host skin
(Oliveira et al., 2009).
We also observed that despite the fact that transcriptional lev-
els of SmAP among male and female adult worms are similar, fe-
male parasites express higher protein levels of SmAP and show
an increased surface enzymatic activity. The lack of correlation be-
tween the levels of messenger and its protein end-product has
been related to a range of metabolic and regulatory events (Hokke
et al., 2007). Although it seems strange that egg express high levels
of SmAP, but display low surface activity, this probably reﬂects the
fact that most of the activity should be inside the shells (Dusanic,
1959).
The immunolocalization of SmAP in adult male and female sec-
tions conﬁrmed its ubiquitary tissue distribution. The SmAP anti-
sera also recognized, with a particular intensity, the vitelline
glands in the female tissue, suggesting a special function for SmAP
in some processes associated with egg production, such as protein
and nucleic acid synthesis (Dusanic, 1959).SmAP has been considered a possible target for immune inter-
vention, since it is a tegument surface protein that is postulated
to be involved in worm elimination in the self-curing Rhesusmaca-
que model. Furthermore, the treatment with praziquantel in-
creases the exposure of SmAP on the parasite’s surface and in
this condition, SmAP antisera was able to kill female worms. Based
on this information, we hypothesized that if rSmAP antisera could
block/impair the worm’s Alkaline Phosphatase activity, it may pro-
tect mice against parasite infection in a vaccine trial. However, the
rSmAP antisera did not impair the adult worm surface enzymatic
activity as postulated. This is not the ﬁrst report of the inability
of SmAP antisera to inhibit its enzymatic activity (Pujol et al.,
1990). These studies suggested the presence of two populations
of antibodies against SmAP: one inhibitory and the other non-
inhibitory. Upon analysis of the hypothetical non-glycosylated
3D-model, at least two potential B-cell discontinuous epitopes
can be visualized in the vicinity of the active site, and many others
around the molecule. Antibodies targeting these sites would not
neutralize the active or metal binding sites, being non-inhibitory
antibodies. It has been hypothesized that the induction of high ti-
ters of neutralizing antibody is important for the development of
an effective vaccine. If this is the case, it would be important to
produce an active recombinant molecule in the eukaryotic Pichia
pastoris system, in order to obtain a protein in the native conforma-
tion to be evaluated as a potential vaccine candidate in the schis-
tosomiasis murine model.
Our results present the ﬁrst evidence that schistosomes in the
cercarial phase prepare to produce large quantities of Alkaline
Phosphatase by accumulating mRNA, to be able to rapidly translate
it into protein upon invasion of the host and transformation into
schistosomula, indicating its important role in invasion. Putative
functions as immune modulators have been suggested (Bhardwaj
and Skelly, 2011). On a whole, these results support this molecule
as an important target for immune intervention.
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